Malignant Neoplasm — Trials

Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

90,662 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20,108
Recruiting: 10,888
Ph III recruiting: 1,278
Growth YoY: +12.8%
Industry share: 20%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 29.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (11,158)

clinicaltrialsPublishedShowing 101–150 of 1,399 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06361810	PSMA Therapy and Immunotherapy in Kidney Cancer	withdrawn	Phase 1 / Phase 2	0	Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER	0	Aug 19, 2025	clinicaltrials
NCT04756765	Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer	withdrawn	Phase 2	0	Stanford UniversityOTHER	1	Aug 17, 2025	clinicaltrials